Gender and functional outcomes in prestroke depressive patients treated with thrombolytic therapy.

Autor: Tate, Mandy J, Shugart, Rachel M, Moraney, Robyn A, Brechtel, Leanne E, Blum, Brice, Thomas I Nathaniel
Zdroj: Future Neurology; Apr2020, Vol. 15 Issue 2, pN.PAG-N.PAG, 3p
Abstrakt: Aim: This study investigated the clinical factors associated with functional ambulatory outcomes and gender differences in prestroke depressive patients. Materials & methods: Clinical risk factors associated with improved functional outcomes with recombinant tissue plasminogen activator-treated cohorts were determined using binary logistic regression. Results: In the adjusted analysis, improvement in ambulation was associated with male patients that had higher National Institute of Health stroke scale score (p = 0.04), a stroke history (p = 0.026), lower serum creatinine levels (p = 0.049) and were taking cholesterol reducing medication (p = 0.014). Improvement in females was associated with taking antidepressants (p = 0.027) and having lower National Institute of Health stroke scale score (p = 0.002). Conclusion: Our findings indicate gender disparities between male and female prestroke depressive patients. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index